Showing results (61-70 of 85) with videos related to
Sort By:
Pageof 9
Health and Quality of Life Outcomes|January 17, 2023
Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5LShoki Izumi, Yasuhiro Hagiwara, Yutaka Matsuyama, et al.Breast Cancer Research and Treatment|April 3, 2014
Health-related quality of life and psychological distress during neoadjuvant endocrine therapy with letrozole to determine endocrine responsiveness in postmenopausal breast cancerNaruto Taira, Hiroji Iwata, Yoshie Hasegawa, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 18, 2008
Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)Katsumasa Kuroi, Kojiro Shimozuma, Yasuo Ohashi, et al.Japanese Journal of Clinical Oncology|October 11, 2008
A questionnaire survey of physicians' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancerKatsumasa Kuroi, Kojiro Shimozuma, Yasuo Ohashi, et al.Japanese Journal of Clinical Oncology|March 24, 2017
Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trialMasafumi Oyama, Takayuki Sugiyama, Masahiro Nozawa, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 10, 2006
Clinical validity of the Japanese version of the Functional Assessment of Cancer Therapy-Anemia ScaleMaya Kurita, Kojiro Shimozuma, Satoshi Morita, et al.BMC Cancer|November 19, 2017
Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trialTakeru Shiroiwa, Takashi Fukuda, Kojiro Shimozuma, et al.Pharmacoeconomics - Open|February 10, 2026
Comparative Cost-Effectiveness Analysis of Multiple First-Line Treatments for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer in JapanKosuke Morimoto, Kensuke Moriwaki, Yoshitaka Nishikawa, et al.BMC Health Services Research|March 14, 2024
How to select and understand guidelines for patient-reported outcomes: a scoping review of existing guidanceTakako Kaneyasu, Eri Hoshino, Mariko Naito, et al.Breast Cancer Research and Treatment|June 3, 2021
Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trialYasuhiro Hagiwara, Masataka Sawaki, Yukari Uemura, et al.Pageof 9